Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-17

Clinical Trial Update: A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100) [Phase 3]

View source ↗

Summary

Phase 3 trial update for avelumab in locally advanced or metastatic urothelial cancer (JAVELIN Bladder 100) with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avelumab (avelumab)

Snippet

Sponsor: Pfizer | Conditions: Urothelial Cancer | Phase 3 | Status: COMPLETED | Results posted: 2020-12-17